Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2007 1
2008 1
2009 1
2010 1
2011 2
2012 3
2013 1
2014 3
2015 8
2016 6
2017 4
2018 8
2019 9
2020 6
2021 8
2022 12
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Agashev
Page 1
N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells.
Abakir A, Giles TC, Cristini A, Foster JM, Dai N, Starczak M, Rubio-Roldan A, Li M, Eleftheriou M, Crutchley J, Flatt L, Young L, Gaffney DJ, Denning C, Dalhus B, Emes RD, Gackowski D, Corrêa IR Jr, Garcia-Perez JL, Klungland A, Gromak N, Ruzov A. Abakir A, et al. Nat Genet. 2020 Jan;52(1):48-55. doi: 10.1038/s41588-019-0549-x. Epub 2019 Dec 16. Nat Genet. 2020. PMID: 31844323 Free PMC article.
We demonstrate that m(6)A-containing R-loops accumulate during G(2)/M and are depleted at G(0)/G(1) phases of the cell cycle, and that the m(6)A reader promoting mRNA degradation, YTHDF2 (ref. (7)), interacts with R-loop-enriched loci in dividing cells. Conse …
We demonstrate that m(6)A-containing R-loops accumulate during G(2)/M and are depleted at G(0)/G(1) phases of the cell cycle, …
Reply to F. Dayyani et al.
Kasi PM, Fehringer G, Aleshin A, Kopetz S. Kasi PM, et al. JCO Precis Oncol. 2022 Jul;6:e2200275. doi: 10.1200/PO.22.00275. JCO Precis Oncol. 2022. PMID: 35834757 No abstract available.
Detecting and Mapping N6-Methyladenosine on RNA/DNA Hybrids.
Abakir A, Alenezi F, Ruzov A. Abakir A, et al. Methods Mol Biol. 2022;2528:329-344. doi: 10.1007/978-1-0716-2477-7_22. Methods Mol Biol. 2022. PMID: 35704202
N6-methyladenosine (m(6)A) is an RNA modification essential for posttranscriptional regulation of gene expression in eukaryotes. ...In addition to the m(6)A-focused studies, these methodologies can also contribute to elucidating the functional roles of other RNA mod …
N6-methyladenosine (m(6)A) is an RNA modification essential for posttranscriptional regulation of gene expression in eukaryotes. ...I …
Chromosome ends and the theory of marginotomy: implications for reproduction.
Córdova-Oriz I, Polonio AM, Cuadrado-Torroglosa I, Chico-Sordo L, Medrano M, García-Velasco JA, Varela E. Córdova-Oriz I, et al. Biogerontology. 2024 Apr;25(2):227-248. doi: 10.1007/s10522-023-10071-w. Epub 2023 Nov 9. Biogerontology. 2024. PMID: 37943366 Review.
They were first described in the 1930s, but their biology remained unexplored until the early 70s, when Alexey M. Olovnikov, a theoretical biologist, suggested that telomeres cannot be fully copied during DNA replication. ...
They were first described in the 1930s, but their biology remained unexplored until the early 70s, when Alexey M. Olovnikov, a …
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Chastre J, François B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, Sánchez-García M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS; COMBACTE-MAGNET EVADE Study Group. Chastre J, et al. Crit Care. 2022 Nov 15;26(1):355. doi: 10.1186/s13054-022-04204-9. Crit Care. 2022. PMID: 36380312 Free PMC article. Clinical Trial.
Reply to S. Chakrabarti and A. Mahipal.
Huffman BM, Jurdi A, Aleshin A, Liu MC, Klempner SJ. Huffman BM, et al. JCO Precis Oncol. 2023 Mar;7:e2300043. doi: 10.1200/PO.23.00043. JCO Precis Oncol. 2023. PMID: 36952643 No abstract available.
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.
Kasi PM, Fehringer G, Taniguchi H, Starling N, Nakamura Y, Kotani D, Powles T, Li BT, Pusztai L, Aushev VN, Kalashnikova E, Sharma S, Malhotra M, Demko ZP, Aleshin A, Rodriguez A, Billings PR, Grothey A, Taieb J, Cunningham D, Yoshino T, Kopetz S. Kasi PM, et al. JCO Precis Oncol. 2022 Mar;6:e2100181. doi: 10.1200/PO.21.00181. JCO Precis Oncol. 2022. PMID: 35263168 Free PMC article. Review.
75 results